Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery-Systematic review and meta-analysis.
João PresumeJorge FerreiraRegina RibeirasMiguel MendesPublished in: Journal of thrombosis and haemostasis : JTH (2022)
Factor XI inhibitors showed a significant reduction in the incidence of VTE and bleeding events among patients submitted to major orthopedic surgery.